TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
AGB-Pharma AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
200,937
|
256,602
|
229,142 |
| Financial expenses |
2,106
|
806
|
7 |
| Earnings before taxes |
5,967
|
85,276
|
117,171 |
| EBITDA |
2,503
|
82,302
|
115,852 |
| Total assets |
99,286
|
187,334
|
169,194 |
| Current assets |
87,895
|
177,040
|
161,682 |
| Current liabilities |
47,498
|
82,328
|
50,779 |
| Equity capital |
42,917
|
98,147
|
114,203 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
20
|
17
|
11 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
43.2%
|
52.4%
|
67.5% |
| Turnover per employee |
10,047
|
15,094
|
20,831 |
| Profit as a percentage of turnover |
3.0%
|
33.2%
|
51.1% |
| Return on assets (ROA) |
8.1%
|
46.0%
|
69.3% |
| Current ratio |
185.0%
|
215.0%
|
318.4% |
| Return on equity (ROE) |
13.9%
|
86.9%
|
102.6% |
| Change turnover |
-60,292
|
11,201
|
71,619 |
| Change turnover % |
-23%
|
5%
|
45% |
| Chg. No. of employees |
3
|
6
|
5 |
| Chg. No. of employees % |
18%
|
55%
|
83% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.